Tag Archives: DERM

Top 5 High Tech Stocks For 2019

Tata Consultancy Services share price fell nearly 5 percent intraday Thursday ahead of July-September quarter earnings due later in the day.

The stock price was quoting at Rs 2,006.25, down Rs 36.80, or 1.80 percent at 13:01 hours IST. In previous session also, it closed 2.27 percent lower on the BSE.

The country’s largest software services exporter is likely to report strong earnings for second quarter almost all analysts on the Street have already predicted that the rupee tailwind is likely to play a big role in earnings of IT companies.

“Improving deal wins, higher share of digital segment and reducing pressure on legacy business are expected to be key drivers of growth in the quarter, coupled with Q2 being a seasonally strong quarter,” ICICI Securities said.

related news Asian Paints falls 2% even as BofAML sees an upside of 35% D-Street Buzz: PSU bank, IT stocks fall the most led by SBI, Infibeam; RIL recovers, HEG zooms 14% Aurobindo Pharma slips 3%; gets USFDA approval for anti-infection drug

Most analysts expect TCS to lead the sector with revenue growth in the range of 3.5-4.5 percent, sequentially.

Top 5 High Tech Stocks For 2019: Citigroup Inc.(BLW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    First Foundation Advisors reduced its position in shares of Blackrock Limited Duration (NYSE:BLW) by 8.4% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 322,389 shares of the investment management company’s stock after selling 29,591 shares during the period. First Foundation Advisors owned approximately 0.87% of Blackrock Limited Duration worth $4,862,000 as of its most recent SEC filing.

Top 5 High Tech Stocks For 2019: State Bank Financial Corporation.(STBZ)

Advisors’ Opinion:

  • [By Max Byerly]

    Citizens Financial Group (NYSE:CFG) and State Bank Financial (NASDAQ:STBZ) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By Logan Wallace]

    State Bank Financial (NASDAQ:STBZ) last issued its quarterly earnings results on Thursday, January 25th. The financial services provider reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. State Bank Financial had a return on equity of 9.26% and a net margin of 18.77%. The firm had revenue of $68.16 million during the quarter, compared to the consensus estimate of $65.00 million. analysts expect that State Bank Financial will post 2.18 EPS for the current year.

    TRADEMARK VIOLATION WARNING: “Analysts Set State Bank Financial (STBZ) PT at $34.00” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3379591/analysts-set-state-bank-financial-stbz-pt-at-34-00.html.

    State Bank Financial Company Profile

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on State Bank Financial (STBZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 High Tech Stocks For 2019: VivoPower International PLC (VVPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company reported preliminary first-quarter results. The company said its first quarter revenue rose 286 percent from the same quarter a year ago to $712,000.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 34.5 percent to $4.52 after the company announced it would proceed with Phase 3 development of GR-MD-02 for NASH Cirrhosis following the FDA meeting.
    Boxlight Corporation (NASDAQ: BOXL) shares rose 21.9 percent to $8.1063.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16 percent to $15.65.
    Myomo, Inc. (NYSE: MYO) shares jumped 15.5 percent to $3.6263 after the company disclosed that its application for Medicare codes received favorable preliminary decision.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) rose 13.7 percent to $10.12.
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 13.7 percent to $4.6743.
    Acacia Communications, Inc. (NASDAQ: ACIA) shares gained 12.2 percent to $35.34 as optical sector is seeing strength following President Trump's announcement that he would work with China related to ZTE Corp.
    Tailored Brands, Inc. (NYSE: TLRD) shares rose 11.3 percent to $35.17. Jefferies upgraded Tailored Brands from Hold to Buy.
    Kona Grill, Inc. (NASDAQ: KONA) jumped 10.6 percent to $2.875.
    Federated National Holding Company (NASDAQ: FNHC) shares rose 10.6 percent to $20.29. Raymond James upgraded Federated National Holding from Outperform to Strong Buy.
    Renewable Energy Group, Inc. (NASDAQ: REGI) climbed 10.2 percent to $15.15. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 10.1 percent to $3.16. Stein Mart is expected to release Q1 earnings on May 23.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 9.7 percent to $108.60 after Bloomberg reported that the China’s Commerce Ministry has restar
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

  • [By Lisa Levin] Gainers
    athenahealth, Inc. (NASDAQ: ATHN) shares climbed 23.2 percent to $155.19 after Elliott Management confirmed a $160 per share cash offer for athenahealth.
    Evolus, Inc. (NASDAQ: EOLS) gained 21.3 percent to $8.83. Evolus named David Moatazedi as new CEO.
    VivoPower International PLC (NASDAQ: VVPR) climbed 18.2 percent to $3.12 after falling 39.86 percent on Friday.
    Gramercy Property Trust (NYSE: GPT) rose 15.6 percent to $27.53 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    EP Energy Corporation (NYSE: EPE) rose 13 percent to $2.26.
    Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) gained 11.9 percent to $7.35.
    National CineMedia, Inc. (NASDAQ: NCMI) surged 11.8 percent to $6.24 after the company posted upbeat quarterly profit.
    Sanchez Energy Corporation (NYSE: SN) shares gained 11.3 percent to $3.56.
    CVR Refining, LP (NYSE: CVRR) shares rose 8.8 percent to $18.875.
    Monaker Group, Inc. (NASDAQ: MKGI) rose 8.7 percent to $2.9683.
    Kosmos Energy Ltd. (NYSE: KOS) shares rose 7.4 percent to $7.40.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 7 percent to $2.88 after climbing 1.89 percent on Friday.
    Cloudera, Inc. (NYSE: CLDR) surged 6 percent to $15.93. Craig-Hallum initiated coverage on Cloudera with a Buy rating.
    Illumina, Inc. (NASDAQ: ILMN) rose 5.1 percent to $257.35. Barclays upgraded Illumina from Equal-Weight to Overweight.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Money Morning Staff Reports]

    Take a look at last week’s top-performing penny stocks below, and then we’ll show you how we found the next penny stock on our radar:

    Penny Stock Current Share Price Last Week’s Gain
    Atossa Genetics Inc. (NASDAQ: ATOS) $3.51 134.00%
    Akari Therapeutics Plc. (NASDAQ: AKTX) $4.08 122.96%
    Soleno Therapeutics Inc. (NASDAQ: SLNO) $2.68 78.67%
    Handcock Jaffe Laboratories Inc. (NASDAQ: HJLI) $2.35 66.67%
    ConforMIS Inc. (NASDAQ: CFMS) $1.78 54.76%
    Smart Sand Inc. (NASDAQ: SND) $3.99 46.69%
    Avinger Inc. (NASDAQ: AVGR) $0.89 45.19%
    VivoPower International Plc. (NASDAQ: VVPR) $1.55 44.86%
    Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) $0.92 43.64%
    Genprx Inc. (NASDAQ: GNPX) $2.10 42.86%

    As last week’s returns show, the right penny stocks can crush the broader market’s lackluster returns.

Top 5 High Tech Stocks For 2019: J.B. Hunt Transport Services Inc.(JBHT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    J B Hunt Transport Services (NASDAQ:JBHT) released its quarterly earnings data on Monday. The transportation company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.28 by $0.09, Bloomberg Earnings reports. The company had revenue of $2.14 billion for the quarter, compared to analyst estimates of $2.05 billion. J B Hunt Transport Services had a return on equity of 26.63% and a net margin of 9.54%. The firm’s revenue was up 23.9% compared to the same quarter last year. During the same period last year, the company posted $0.88 earnings per share.

  • [By Stephan Byrd]

    Rhumbline Advisers grew its position in shares of J B Hunt Transport Services Inc (NASDAQ:JBHT) by 7.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 194,057 shares of the transportation company’s stock after purchasing an additional 13,292 shares during the period. Rhumbline Advisers owned 0.18% of J B Hunt Transport Services worth $23,588,000 at the end of the most recent quarter.

  • [By ]

    But then there’s the little-known trucking company JB Hunt (JBHT) , which popped 6.1% because the company saw some surprise growth that no one was expecting. That news was so strong, FedEx (FDX) and XPO Logistics (XPO) also rose 2.2% and 4.6%.

  • [By Ethan Ryder]

    LMR Partners LLP decreased its position in shares of J B Hunt Transport Services Inc (NASDAQ:JBHT) by 72.3% during the second quarter, according to its most recent filing with the SEC. The firm owned 2,688 shares of the transportation company’s stock after selling 7,025 shares during the period. LMR Partners LLP’s holdings in J B Hunt Transport Services were worth $327,000 at the end of the most recent quarter.

  • [By Garrett Baldwin]

    The ongoing trade rift between the United States and China continues to plague international markets. Despite reports that both countries are working behind the scenes to prevent additional detrimental trade policies, both countries recently proposed tens of billions in new tariffs on one another. The United States has accused China of widespread intellectual property theft, while China has accused the United States of unfair trade practices, including price manipulation in the agricultural industry. This morning, it’s worth noting that proposed tariffs on U.S. business jets will likely not provide a competitive advantage to foreign competition. Reuters reports that Chinese aviation executives do not see the layer of protectionism as a way to bolster the nation’s local market. Check back to Money Morning today for more insight on how the ongoing trade war could affect your investments.
    Finally, investors will continue to monitor ongoing developments in Washington around the presidency of Donald Trump. The White House has asked a federal judge to block prosecutors from reviewing any files seized from his lawyer’s office during a raid by the FBI last week. The agency seized a trove of documents from lawyer Michael Cohen’s office as part of an investigation into a payment of hush money. The spat between the White House and the FBI continues a day after former FBI Director James Comey called Trump “morally unfit to be president.”
    Three Stocks to Watch Today: BAC, NFLX, AAPL
    Shares of Bank of America Corp. (NYSE: BAC) added nearly 1% after the nation’s largest bank by deposits topped Wall Street earning expectations. The financial institution leads a busy day of earnings reports on Wall Street and hopes to keep its positive momentum from previous quarters. The firm reported earnings per share of $0.62 on top of $23.27 billion in revenue. That topped expectations of $0.59 on top of $22.91 billion thanks to strong growth in its consumer loan business and the r

Top 5 High Tech Stocks For 2019: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Dermira Inc (NASDAQ:DERM) CEO Thomas G. Wiggans bought 12,000 shares of the business’s stock in a transaction on Monday, July 9th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $120,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

  • [By Ethan Ryder]

    Dermira Inc (NASDAQ:DERM) has earned a consensus recommendation of “Buy” from the eight analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $20.33.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Dermira (DERM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Dermira Inc. (NASDAQ: DERM) shares made a solid gain to close out the week after the firm announced a key approval from the U.S. Food and Drug Administration (FDA). Essentially, the agency approved Qbrexza (glycopyrronium) cloth.

  • [By Shane Hupp]

    Dermira (NASDAQ:DERM) has been given a $20.00 price target by Cantor Fitzgerald in a research note issued to investors on Thursday. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 146.61% from the company’s previous close. Cantor Fitzgerald also issued estimates for Dermira’s FY2018 earnings at ($4.63) EPS.

Best Undervalued Stocks To Watch Right Now

Amaya’s stock has been on a wild roller coaster ride this year, with catalysts ranging from the CEO (David Baazov) being accused of insider trading, to takeover rumors, to failed mergers and now a formal bid by the aforementioned CEO. There have certainly been a lot of hopes and headaches, but I believe there is a strong underlining long case to be made on Amaya. I wrote a blog post about it the day before it released its Q3 earnings, my basic argument was that it is intrinsically undervalued due to market overreaction on merger discussions and there was still the possibility of a buyout by the former CEO at a significant upside. It seemed like a win-win. Well, when the earnings were released, not only were the results impressive but Baazov launched a formal bid at C$24 per share (approximately US$18) or a 30% upside from the previous Friday’s Close. Whether this private takeover succeeds or not, this stock is poised for significant long term growth.

Amaya (NASDAQ:AYA) runs the world’s largest online gaming (casino) empire in the world. It runs many valuable brand names especially in the online poker business (PokerStars and Fulltilt) but is now increasingly moving into sports betting and other online casino games. It is also the fastest growing and most well positioned to take advantage of online gambling legalization as well as the inherent scalability of the internet. This is a company which has seen its revenues increase from below US$200M just a few years ago to over US$1.2 BILLION for the trailing twelve months. Reviewing its results and its future growth prospects, it will be clear that this firm is undervalued.

Best Undervalued Stocks To Watch Right Now: NOW Inc.(DNOW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on NOW (DNOW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    NOW (NYSE:DNOW) had its target price lifted by equities researchers at Cowen from $12.00 to $15.00 in a report released on Friday. The brokerage currently has a “market perform” rating on the oil and gas company’s stock. Cowen’s target price indicates a potential downside of 10.87% from the company’s previous close.

  • [By Logan Wallace]

    ValuEngine upgraded shares of DistributionNOW (NYSE:DNOW) from a strong sell rating to a sell rating in a report published on Friday.

    A number of other research analysts have also recently commented on the company. TheStreet upgraded DistributionNOW from a d+ rating to a c rating in a research note on Wednesday, May 16th. Stifel Nicolaus boosted their price objective on DistributionNOW from $13.00 to $15.00 and gave the stock a buy rating in a research note on Thursday, May 3rd. Cowen restated a market perform rating and set a $11.00 price objective (up previously from $9.00) on shares of DistributionNOW in a research note on Thursday, May 3rd. Susquehanna Bancshares set a $11.00 price objective on DistributionNOW and gave the stock a hold rating in a research note on Friday, April 13th. Finally, Credit Suisse Group restated a neutral rating and set a $10.00 price objective (down previously from $12.00) on shares of DistributionNOW in a research note on Tuesday, February 27th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average price target of $13.00.

  • [By Matthew DiLallo]

    Shares of NOW Inc. (NYSE:DNOW) rose sharply on Thursday, increasing more than 15% by 10:45 a.m. EDT after the oil-field equipment distributor posted expectation-beating second-quarter results.

Best Undervalued Stocks To Watch Right Now: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Paul Ausick]

    Dermira Inc. (NASDAQ: DERM) traded down about 64% Monday and posted a new 52-week low of $8.95 after closing Friday at $25.16. The stock’s 52-week high is $38.39. Volume was about 40 times the daily average of around 615,000 shares. The company’s trial of a new acne treatment failed to meet the designated endpoints.

  • [By Maxx Chatsko]

    Shares of skincare pharmaceutical specialist Dermira (NASDAQ:DERM) dropped nearly 23% today after the company hosted its investor and analyst day for 2018. Investors were none too thrilled with the presentations given — and were only reminded about the stinging failure of a once-promising acne drug DRM01 in March. Shares slipped over 64% on that news.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Dermira (DERM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Dermira Inc (NASDAQ:DERM) CEO Thomas G. Wiggans bought 12,000 shares of the business’s stock in a transaction on Monday, July 9th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $120,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

  • [By Ethan Ryder]

    Dermira Inc (NASDAQ:DERM) has earned a consensus recommendation of “Buy” from the eight analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $20.33.

  • [By Shane Hupp]

    Dermira (NASDAQ:DERM) has been given a $20.00 price target by Cantor Fitzgerald in a research note issued to investors on Thursday. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 146.61% from the company’s previous close. Cantor Fitzgerald also issued estimates for Dermira’s FY2018 earnings at ($4.63) EPS.

Best Undervalued Stocks To Watch Right Now: The Kraft Heinz Company(KHC)

Advisors’ Opinion:

  • [By Aksana Fitzpatrick]

    PepsiCo is not alone in its quest for product innovation. Over the past five years, the number of incubator programs in the consumer foods sectors has skyrocketed. Kraft Heinz(NASDAQ:KHC) launched its own incubator — Springboard — earlier this year. Other consumer giants like Kellogg (NYSE:K), General Mills (NYSE:GIS), and Campbell Soup (NYSE:CPB) have similarly jumped into the start-up world.

  • [By Shane Hupp]

    Kraft Heinz Co (NASDAQ:KHC) has earned a consensus recommendation of “Hold” from the twenty-four brokerages that are currently covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $77.85.

  • [By ]

    My favorite defensive stock for the coming bear market is Kraft Heinz (Nasdaq: KHC). The stock fits both as a defensive stock and as a stock that has been beat lower — our third bear market search criteria.

  • [By Ethan Ryder]

    Kraft Heinz Co (NASDAQ:KHC) was the target of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 30,256,970 shares, a decline of 10.2% from the July 13th total of 33,710,707 shares. Approximately 3.2% of the shares of the company are sold short. Based on an average daily volume of 4,957,878 shares, the short-interest ratio is currently 6.1 days.

  • [By Daniel Sparks]

    Campbell’s stock was pulled down as Kraft Heinz (NASDAQ:KHC) announced a large writedown on the value of some of its well-known brands, and reported higher-than-expected costs for its fourth quarter. Kraft Heinz’s 27% decline as of this writing weighed on the food sector, prompting worries about the industry’s prospects.

  • [By Chris Hill]

    Hill: — that bears further investigation. As a reminder, it was back in May that Campbell Soup said that it was undergoing a strategic review. And, yes, of course, any time you hear, “We’re undertaking a strategic review,” one of the questions on the table is, “Should we be putting ourselves up for sale?” That’s when CEO Denise Morrison said, “Check, please,” and she left. Now, we’re getting reports that Kraft Heinz (NASDAQ:KHC) might be looking to buy Campbell Soup, and shares are up 10%.

Best Undervalued Stocks To Watch Right Now: Liberty Tax, Inc.(TAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Best Undervalued Stocks To Watch Right Now: PAREXEL International Corporation(PRXL)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PAREXEL International earned a news impact score of 0.18 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 49.4978250148766 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Best Undervalued Stocks To Watch Right Now: KapStone Paper and Packaging Corporation(KS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    These are some of the media headlines that may have impacted Accern Sentiment’s rankings:

    Get Kapstone alerts:

    Investor Interest Amplifies Stock EV For KapStone Paper and Packaging Corporation (NYSE:KS) (parkcitycaller.com) What is Clear choice Buy, Sell or Hold? KapStone Paper and Packaging Corporation (KS) (nysestocks.review) Is this stock is suitable for your portfolio? KapStone Paper and Packaging Corporation (KS) (stockquote.review) Investor Buzz: Earnings in Review for KapStone Paper and Packaging Corporation (NYSE:KS) (fisherbusinessnews.com) Kapstone (KS) vs. P H Glatfelter (GLT) Head-To-Head Survey (americanbankingnews.com)

    Several research analysts have issued reports on the company. Deutsche Bank cut Kapstone from a “buy” rating to a “hold” rating and set a $35.00 price target on the stock. in a report on Thursday, February 8th. ValuEngine raised Kapstone from a “hold” rating to a “buy” rating in a report on Thursday, February 8th. Zacks Investment Research raised Kapstone from a “hold” rating to a “buy” rating and set a $39.00 price target on the stock in a report on Wednesday, January 31st. Citigroup reaffirmed a “neutral” rating and issued a $26.00 price target on shares of Kapstone in a report on Tuesday, January 30th. Finally, BMO Capital Markets cut Kapstone from an “outperform” rating to a “market perform” rating in a report on Tuesday, January 30th. Eight equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Kapstone currently has an average rating of “Hold” and an average target price of $32.17.

  • [By Max Byerly]

    KapStone Paper and Packaging Corp. (NYSE:KS) was the target of unusually large options trading activity on Tuesday. Traders acquired 1,489 put options on the company. This is an increase of approximately 2,227% compared to the typical daily volume of 64 put options.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Kapstone (KS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Kapstone (NYSE:KS) has been given a consensus recommendation of “Hold” by the twelve ratings firms that are currently covering the firm, MarketBeat reports. Eight research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $32.60.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on KapStone Paper and Packaging (KS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Watch For 2019

Major market benchmarks fell in Tuesday’s shortened session ahead of the July 4 holiday, giving back earlier gains as investors weighed the effects of a potential trade war, with new tariffs to be imposed on Chinese products later this week.

But some individual stocks easily outperformed the rest. Read on to learn what had Campbells Soup Company (NYSE:CPB), Veon (NASDAQ:VEON), and AZZ (NYSE:AZZ) climbing higher today.

Image source: Getty Images.

This investor wants Campbell Soup to sell

Shares of Campbell Soup climbed 1.9% after The New York Post reported that activist investor Dan Loeb is planning a “major shakeup” at the company with the help of large stakeholders. 

Arguing that Campbell Soup stock is undervalued, Loeb’s Third Point hedge fund is conversing with family members, who control roughly 41% of Campbell’s total shares, as well as other independent investors to encourage Campbell Soup to hire a bank to explore a possible sale of the company. For perspective, last month Campbell announced a broader strategic review of its plans and product portfolio. Now, however, The Post says Loeb is requesting that Campbell Soup abandon all other alternatives to focus exclusively on a sale. 

Top 10 Undervalued Stocks To Watch For 2019: NeuroMetrix Inc.(NURO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Haemonetics (NYSE: HAE) and Neurometrix (NASDAQ:NURO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations.

  • [By Logan Wallace]

    Obalon Therapeutics (NASDAQ: OBLN) and Neurometrix (NASDAQ:NURO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability.

Top 10 Undervalued Stocks To Watch For 2019: EOG Resources, Inc.(EOG)

Advisors’ Opinion:

  • [By Logan Wallace]

    Beese Fulmer Investment Management Inc. boosted its holdings in shares of EOG Resources Inc (NYSE:EOG) by 1.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 53,371 shares of the energy exploration company’s stock after purchasing an additional 861 shares during the period. EOG Resources makes up 1.3% of Beese Fulmer Investment Management Inc.’s investment portfolio, making the stock its 24th largest holding. Beese Fulmer Investment Management Inc.’s holdings in EOG Resources were worth $6,809,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Investors sold shares of EOG Resources (NYSE:EOG) on strength during trading hours on Thursday. $133.11 million flowed into the stock on the tick-up and $162.08 million flowed out of the stock on the tick-down, for a money net flow of $28.97 million out of the stock. Of all companies tracked, EOG Resources had the 14th highest net out-flow for the day. EOG Resources traded up $4.65 for the day and closed at $126.15

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to today’s report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded down about 0.3% to $80.59, in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded up about 0.3%, at $4.52 in a 52-week range of $2.53 to $5.60. EOG Resources Inc. (NYSE: EOG) traded up about 0.3% to $119.12. The 52-week range is $83.61 to $131.60.

    The United States Natural Gas ETF (NYSEARCA: UNG) traded down about 0.3%, at $23.47 in a 52-week range of $20.40 to $27.92.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to this latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded down about 0.2%, at $85.99 in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 0.7%, at $4.70 in a 52-week range of $2.53 to $5.60. EOG Resources Inc. (NYSE: EOG) traded down about 0.3% to $129.99. The 52-week range is $95.36 to $131.60.

    Meanwhile, the United States Natural Gas ETF (NYSEARCA: UNG) traded down about 2%, at $26.32 in a 52-week range of $20.40 to $27.43.

Top 10 Undervalued Stocks To Watch For 2019: Northgate Minerals Corporation(NXG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of NEX Group PLC (LON:NXG) have been given an average rating of “Hold” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 696 ($9.21).

Top 10 Undervalued Stocks To Watch For 2019: Amgen Inc.(AMGN)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Investors are beginning to wonder if bluebird bio is at risk of losing market share before it really even begins life as a commercial company. The latest example: In September Amgen (NASDAQ:AMGN) released promising preliminary data from a small ongoing phase 1 trial, investigating a new immunotherapy as a potential treatment for advanced multiple myeloma. While the initial data release included just five patients, all had failed to respond to between four and six previous treatments. Amgen’s drug, AMG-420, a “simpler” immunotherapy compared to the cellular therapies being developed by bluebird bio and Celgene, resulted in a complete remission in four of them. That’s very impressive.

  • [By Max Byerly]

    Gables Capital Management Inc. purchased a new stake in Amgen, Inc. (NASDAQ:AMGN) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,023 shares of the medical research company’s stock, valued at approximately $174,000.

  • [By Keith Speights]

    That difficulty hasn’t stopped market research firm EvaluatePharma from trying, though. EvaluatePharma recently published a list of the drugmakers with the projected highest value creation from pipeline products between 2018 and 2024. Here’s why Novartis (NYSE:NVS), AbbVie (NYSE:ABBV), Celgene (NASDAQ:CELG), AstraZeneca (NYSE:AZN), and Amgen (NASDAQ:AMGN) ranked at the top.

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Amgen (NASDAQ:AMGN), and Johnson & Johnson (NYSE:JNJ) rank as the three top biopharmaceutical companies when it comes to cash stockpiles. Here’s what these drugmakers are most likely to do with all that money — and whether or not you should consider investing some of your hard-earned cash to buy their stocks.

  • [By Chris Lange]

    Amgen Inc. (NASDAQ: AMGN) saw its short interest fall to 9.62 million shares from the previous level of 9.79 million. Shares were last seen at $178.26, in a 52-week trading range of $153.56 to $201.23.

  • [By Cory Renauer]

    Lilly investors can also look forward to growing sales of the third new treatment for the prevention of migraine headaches. Emgality launched in October months after competing treatments from Amgen (NASDAQ:AMGN) and Teva Pharmaceuticals (NYSE:TEVA) late last year.

Top 10 Undervalued Stocks To Watch For 2019: Celestica, Inc.(CLS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lessened its holdings in Celestica Inc (NYSE:CLS) (TSE:CLS) by 18.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,492,435 shares of the technology company’s stock after selling 343,300 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 1.20% of Celestica worth $19,894,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get Celestica alerts:

    Global White Box Server Market Trend 2018- Quanta, Wistron, Inventec, Hon Hai, MiTAC, Celestica, Super Micro … (nwctrail.com) Taking Aim at Celestica Inc (CLS) Shares (parkcitycaller.com) When to Buy Opportunity? Celestica Inc. (CLS) (nysestocks.review) Electronic Manufacturing Services (EMS) Market 2018: Global Analysis by Key Players – Foxconn, Flextronics, Celestica (industrytoday.co.uk) Riveting Stock Watch: Celestica Inc. (TSX:CLS) Earnings Growth in the Spotlight (derbynewsjournal.com)

    A number of equities research analysts have recently issued reports on the company. TheStreet upgraded Celestica from a “c+” rating to a “b-” rating in a research note on Monday, May 7th. Zacks Investment Research cut Celestica from a “hold” rating to a “sell” rating in a research note on Thursday, May 3rd. Royal Bank of Canada upped their price objective on Celestica from $11.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Monday, April 30th. Finally, Beacon Securities reiterated a “buy” rating on shares of Celestica in a research note on Monday, January 29th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $13.27.

  • [By Evan Niu, CFA]

    Shares of Celestica (NYSE:CLS) have plunged today, down by 16% as of 10:45 a.m. EST, after the company reported fourth-quarter earnings results. The electronics manufacturing specialist missed earnings estimates and forecast first-quarter earnings below expectations as well.

Top 10 Undervalued Stocks To Watch For 2019: One Liberty Properties Inc.(OLP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    One Liberty Properties, Inc. (NYSE:OLP) declared a quarterly dividend on Friday, September 14th, Wall Street Journal reports. Shareholders of record on Tuesday, September 25th will be paid a dividend of 0.45 per share by the real estate investment trust on Thursday, October 4th. This represents a $1.80 annualized dividend and a yield of 6.36%. The ex-dividend date is Monday, September 24th.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on One Liberty Properties (OLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    One Liberty Properties, Inc. (NYSE:OLP) VP Justin Clair sold 3,100 shares of the company’s stock in a transaction dated Monday, May 21st. The stock was sold at an average price of $25.00, for a total value of $77,500.00. Following the completion of the transaction, the vice president now directly owns 32,566 shares in the company, valued at $814,150. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on One Liberty Properties (OLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Watch For 2019: OncoSec Medical Incorporated(ONCS)

Advisors’ Opinion:

  • [By Max Byerly]

    OncoSec Medical Inc (NASDAQ:ONCS) traded up 5.9% on Wednesday . The stock traded as high as $1.45 and last traded at $1.43. 506,563 shares changed hands during mid-day trading, a decline of 31% from the average session volume of 730,660 shares. The stock had previously closed at $1.35.

  • [By Logan Wallace]

    Here are some of the headlines that may have effected Accern Sentiment’s rankings:

    Get OncoSec Medical alerts:

    OncoSec Medical (ONCS) Given Buy Rating at Dawson James (americanbankingnews.com) OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer (finance.yahoo.com) OncoSec appoints Sara M. Bonstein as CFO and COO (seekingalpha.com) Oncosec Medical (ONCS) Appoints Sara M. Bonstein as CFO and COO (streetinsider.com) OncoSec Appoints Sara M. Bonstein as Chief Financial Officer and Chief Operating Officer (finance.yahoo.com)

    ONCS stock traded down $0.02 during trading on Thursday, reaching $1.28. The company’s stock had a trading volume of 367,800 shares, compared to its average volume of 916,959. OncoSec Medical has a 1 year low of $0.88 and a 1 year high of $2.95. The firm has a market capitalization of $68.05 million, a PE ratio of -1.21 and a beta of 2.98.

  • [By Stephan Byrd]

    HC Wainwright set a $4.00 price target on OncoSec Medical (NASDAQ:ONCS) in a research report released on Tuesday. The firm currently has a buy rating on the biotechnology company’s stock.

Top 10 Undervalued Stocks To Watch For 2019: CBRE Group, Inc.(CBG)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Jeff Ubben’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben

    These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,

  • [By Ethan Ryder]

    Peel Hunt reaffirmed their hold rating on shares of Close Brothers Group (LON:CBG) in a report issued on Tuesday.

    Several other equities research analysts also recently issued reports on CBG. Shore Capital reiterated a hold rating on shares of Close Brothers Group in a report on Wednesday, July 18th. Numis Securities upgraded Close Brothers Group to an add rating in a report on Wednesday, July 18th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of GBX 1,561.30 ($20.34).

Top 10 Undervalued Stocks To Watch For 2019: SharpSpring, Inc.(SHSP)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By WWW.GURUFOCUS.COM]

    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

Top 10 Undervalued Stocks To Watch For 2019: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of skincare pharmaceutical specialist Dermira (NASDAQ:DERM) dropped nearly 23% today after the company hosted its investor and analyst day for 2018. Investors were none too thrilled with the presentations given — and were only reminded about the stinging failure of a once-promising acne drug DRM01 in March. Shares slipped over 64% on that news.

  • [By Paul Ausick]

    Dermira Inc. (NASDAQ: DERM) traded down about 64% Monday and posted a new 52-week low of $8.95 after closing Friday at $25.16. The stock’s 52-week high is $38.39. Volume was about 40 times the daily average of around 615,000 shares. The company’s trial of a new acne treatment failed to meet the designated endpoints.

  • [By Shane Hupp]

    Dermira (NASDAQ:DERM) has been given a $20.00 price target by Cantor Fitzgerald in a research note issued to investors on Thursday. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 146.61% from the company’s previous close. Cantor Fitzgerald also issued estimates for Dermira’s FY2018 earnings at ($4.63) EPS.

Top Dividend Stocks To Invest In Right Now

istar (NYSE:STAR) and Corporate Office Properties Trust (NYSE:OFC) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, profitability, risk and institutional ownership.

Volatility & Risk

Get istar alerts:

istar has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Comparatively, Corporate Office Properties Trust has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500.

Dividends

istar pays an annual dividend of $0.36 per share and has a dividend yield of 3.3%. Corporate Office Properties Trust pays an annual dividend of $1.10 per share and has a dividend yield of 3.9%. istar pays out 15.6% of its earnings in the form of a dividend. Corporate Office Properties Trust pays out 54.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Top Dividend Stocks To Invest In Right Now: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of skincare pharmaceutical specialist Dermira (NASDAQ:DERM) dropped nearly 23% today after the company hosted its investor and analyst day for 2018. Investors were none too thrilled with the presentations given — and were only reminded about the stinging failure of a once-promising acne drug DRM01 in March. Shares slipped over 64% on that news.

  • [By Chris Lange]

    Dermira Inc. (NASDAQ: DERM) shares made a solid gain to close out the week after the firm announced a key approval from the U.S. Food and Drug Administration (FDA). Essentially, the agency approved Qbrexza (glycopyrronium) cloth.

  • [By Chris Lange]

    Dermira Inc. (NASDAQ: DERM) watched its shares absolutely collapse early on Monday after the firm reported disappointing results from its late-stage trials in patients with acne vulgaris. Essentially, Dermira’s Phase 3 trials of the investigational treatment olumacostat glasaretil (formerly DRM01) did not meet the co-primary endpoints.

  • [By Paul Ausick]

    Dermira Inc. (NASDAQ: DERM) traded down about 64% Monday and posted a new 52-week low of $8.95 after closing Friday at $25.16. The stock’s 52-week high is $38.39. Volume was about 40 times the daily average of around 615,000 shares. The company’s trial of a new acne treatment failed to meet the designated endpoints.

  • [By Stephan Byrd]

    Dermira Inc (NASDAQ:DERM) CEO Thomas G. Wiggans bought 12,000 shares of the business’s stock in a transaction on Monday, July 9th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $120,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

Top Dividend Stocks To Invest In Right Now: NorthStar Realty Europe Corp.(NRE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Teachers Insurance & Annuity Association of America increased its holdings in NorthStar Realty Europe (NYSE:NRE) by 15.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 71,499 shares of the financial services provider’s stock after purchasing an additional 9,699 shares during the period. Teachers Insurance & Annuity Association of America owned approximately 0.13% of NorthStar Realty Europe worth $931,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Northstar Realty Europe Corp (NYSE:NRE) has earned an average rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $16.83.

  • [By Joseph Griffin]

    Pebblebrook Hotel Trust (NYSE: NRE) and Northstar Realty Europe (NYSE:NRE) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

  • [By Jim Royal]

    Investors in NorthStar Realty Europe (NYSE:NRE) woke up to news Tuesday morning that one of the company’s largest investors is looking to shake things up at the company. Senvest Management, which owns 9.55% of NorthStar, is pushing the company’s external advisor, Colony Capital (NYSE:CLNY), to realize value at the undervalued European REIT, after years of a stagnating stock price.

Top Dividend Stocks To Invest In Right Now: Imprimis Pharmaceuticals, Inc.(IMMY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Stephan Byrd]

    Headlines about Imprimis Pharmaceuticals (NASDAQ:IMMY) have been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imprimis Pharmaceuticals earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the specialty pharmaceutical company an impact score of 47.393314841388 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t

Best Performing Stocks To Invest In Right Now

The 10-year Treasury yield hit a four-year high on Friday after the latest jobs report showed solid wage gains, effectively confirming the expected rate increase at the Federal Reserves next meeting in March.

How are Treasurys performing?

The yield on the 10-year Treasury note
TMUBMUSD10Y, +1.57%
climbed 6.6 basis points to 2.839%, the highest since Jan. 2014.

Best Performing Stocks To Invest In Right Now: LookSmart Ltd.(LOOK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Peel Hunt reissued their buy rating on shares of Lookers (LON:LOOK) in a research note issued to investors on Wednesday morning.

    A number of other equities analysts also recently weighed in on the stock. Numis Securities reaffirmed a buy rating and issued a GBX 130 ($1.76) price target on shares of Lookers in a research note on Wednesday, March 7th. JPMorgan Chase upped their price target on shares of Lookers from GBX 109 ($1.48) to GBX 130 ($1.76) and gave the stock an overweight rating in a research note on Thursday, March 8th. Liberum Capital reaffirmed a buy rating and issued a GBX 145 ($1.97) price target on shares of Lookers in a research note on Wednesday, March 7th. Finally, Canaccord Genuity reaffirmed a buy rating and issued a GBX 146 ($1.98) price target on shares of Lookers in a research note on Monday, March 5th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Lookers has an average rating of Buy and an average price target of GBX 137.71 ($1.87).

Best Performing Stocks To Invest In Right Now: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Dermira (NASDAQ:DERM) has been given a $20.00 price target by Cantor Fitzgerald in a research note issued to investors on Thursday. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 146.61% from the company’s previous close. Cantor Fitzgerald also issued estimates for Dermira’s FY2018 earnings at ($4.63) EPS.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

  • [By Maxx Chatsko]

    Shares of skincare pharmaceutical specialist Dermira (NASDAQ:DERM) dropped nearly 23% today after the company hosted its investor and analyst day for 2018. Investors were none too thrilled with the presentations given — and were only reminded about the stinging failure of a once-promising acne drug DRM01 in March. Shares slipped over 64% on that news.

  • [By Paul Ausick]

    Dermira Inc. (NASDAQ: DERM) traded down about 64% Monday and posted a new 52-week low of $8.95 after closing Friday at $25.16. The stock’s 52-week high is $38.39. Volume was about 40 times the daily average of around 615,000 shares. The company’s trial of a new acne treatment failed to meet the designated endpoints.

  • [By Chris Lange]

    Dermira Inc. (NASDAQ: DERM) watched its shares absolutely collapse early on Monday after the firm reported disappointing results from its late-stage trials in patients with acne vulgaris. Essentially, Dermiras Phase 3 trials of the investigational treatment olumacostat glasaretil (formerly DRM01) did not meet the co-primary endpoints.

Best Performing Stocks To Invest In Right Now: Ishares Trust Dj Us Financial (IYF)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    The challenges facing EUFN may indicate the ETF will be challenged to deliver compelling risk-reward for investors. EUFN's three-year standard deviation is 18.23 percent, or more than 500 basis points above the same metric on the iShares U.S. Financials ETF (NYSE: IYF).